| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M411483200 |
| P698 | PubMed publication ID | 15542593 |
| P2093 | author name string | David M Clarke | |
| M Claire Bartlett | |||
| Tip W Loo | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression | Q24291900 | ||
| A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins | Q24316901 | ||
| ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer | Q24602726 | ||
| Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters | Q24602798 | ||
| The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism | Q27638959 | ||
| Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA | Q28119124 | ||
| Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity | Q28142263 | ||
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Increased diffusional mobility of CFTR at the plasma membrane after deletion of its C-terminal PDZ binding motif | Q33195731 | ||
| A PDZ-interacting domain in CFTR is an apical membrane polarization signal | Q33902133 | ||
| Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation | Q34208379 | ||
| Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor | Q34417118 | ||
| Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy | Q34502736 | ||
| Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. | Q34559072 | ||
| The C terminus of SUR1 is required for trafficking of KATP channels | Q38322919 | ||
| Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence | Q38358911 | ||
| Identification and characterization of functionally important elements in the multidrug resistance protein 1 COOH-terminal region | Q40508859 | ||
| The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium. | Q40513676 | ||
| Site-specific recombination: developments and applications | Q40535474 | ||
| Processing mutations located throughout the human multidrug resistance P-glycoprotein disrupt interactions between the nucleotide binding domains. | Q40537131 | ||
| Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein. | Q40704865 | ||
| PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator | Q40712140 | ||
| Introduction of the most common cystic fibrosis mutation (Delta F508) into human P-glycoprotein disrupts packing of the transmembrane segments. | Q40724271 | ||
| Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism | Q40791919 | ||
| Localization of sequences within the C-terminal domain of the cystic fibrosis transmembrane conductance regulator which impact maturation and stability | Q40850802 | ||
| Cystic fibrosis transmembrane conductance regulator has an altered structure when its maturation is inhibited | Q40891143 | ||
| ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. | Q40891617 | ||
| The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface. | Q40934272 | ||
| Superfolding of the partially unfolded core-glycosylated intermediate of human P-glycoprotein into the mature enzyme is promoted by substrate-induced transmembrane domain interactions. | Q41034671 | ||
| The minimum functional unit of human P-glycoprotein appears to be a monomer. | Q41155410 | ||
| Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities. | Q41295094 | ||
| P-glycoprotein. Associations between domains and between domains and molecular chaperones | Q41295494 | ||
| Membrane topology of a cysteine-less mutant of human P-glycoprotein | Q41380800 | ||
| Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis | Q41714520 | ||
| Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil | Q43560244 | ||
| Determining the dimensions of the drug-binding domain of human P-glycoprotein using thiol cross-linking compounds as molecular rulers | Q43717027 | ||
| Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor | Q44715007 | ||
| Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane | Q57976930 | ||
| Identification of Residues in the Drug-binding Domain of Human P-glycoprotein | Q57976933 | ||
| Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators | Q57976939 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 2522-2528 | |
| P577 | publication date | 2004-11-12 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The dileucine motif at the COOH terminus of human multidrug resistance P-glycoprotein is important for folding but not activity | |
| P478 | volume | 280 |
| Q37119826 | A conserved hydrophobic tetrad near the C terminus of the secretory Na+-K+-2Cl- cotransporter (NKCC1) is required for its correct intracellular processing |
| Q38972586 | Cysteines introduced into extracellular loops 1 and 4 of human P-glycoprotein that are close only in the open conformation spontaneously form a disulfide bond that inhibits drug efflux and ATPase activity. |
| Q35763112 | Dileucine and PDZ-binding motifs mediate synaptic adhesion-like molecule 1 (SALM1) trafficking in hippocampal neurons |
| Q36082562 | Distinct N-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES-SA/Dx5 |
| Q36379776 | Insight in eukaryotic ABC transporter function by mutation analysis |
| Q39354491 | Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition. |
| Q41993227 | Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR). |
| Q28509174 | RPN2 gene confers docetaxel resistance in breast cancer |
| Q38873295 | The Transmission Interfaces Contribute Asymmetrically to the Assembly and Activity of Human P-glycoprotein |
| Q43227854 | The cytoplasmic tail dileucine motif LL572 determines the glycosylation pattern of membrane-type 1 matrix metalloproteinase. |
| Q34745166 | The polarization of the G-protein activated potassium channel GIRK5 to the vegetal pole of Xenopus laevis oocytes is driven by a di-leucine motif |
Search more.